Literature DB >> 21530210

Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.

S Palumbo1, C D Toscano, L Parente, R Weigert, F Bosetti.   

Abstract

Phospholipases A(2) (PLA(2)) are the enzymatic keys for the activation of the arachidonic acid (AA) cascade and the subsequent synthesis of pro-inflammatory prostanoids (prostaglandins and tromboxanes). Prostanoids play critical roles in the initiation and modulation of inflammation and their levels have been reported increased in several neurological and neurodegenerative disorders, including multiple sclerosis (MS). Here, we aimed to determine whether brain expression PLA(2) enzymes and the terminal prostagland in levels are changed during cuprizone-induced demyelination and in the subsequent remyelination phase. Mice were given the neurotoxicant cuprizone through the diet for six weeks to induce brain demyelination. Then, cuprizone was withdrawn and mice were returned to a normal diet for 6 weeks to allow spontaneous remyelination. We found that after 4-6 weeks of cuprizone, sPLA(2)(V) and cPLA(2), but not iPLA(2)(VI), gene expression was upregulated in the cortex, concomitant with an increase in the expression of astrocyte and microglia markers. Cyclooxygenase (COX)-2 gene expression was consistently upregulated during all the demyelination period, whereas COX-1 sporadically increased only at week 5 of cuprizone exposure. However, we found that at the protein level only sPLA(2)(V) and COX-1 were elevated during demyelination, with COX-1 selectively expressed by activated and infiltrated microglia/macrophages and astrocytes. Levels of PGE(2), PGD(2), PGI(2) and TXB(2) were also increased during demyelination. During remyelination, none of the PLA(2) isoforms was significantly changed, whereas COX-1 and -2 were sporadically upregulated only at the gene expression level. PGE(2), PGI(2) and PGD(2) levels returned to normal, whereas TXB(2) was still upregulated after 3 weeks of cuprizone withdrawal. Our study characterizes for the first time time-dependent changes in the AA metabolic pathway during cuprizone-induced demyelination and the subsequent remyelination and suggests that sPLA(2)(V) is the major isoform contributing to AA release. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21530210      PMCID: PMC3109126          DOI: 10.1016/j.plefa.2011.04.001

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  34 in total

1.  Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway.

Authors:  Katsuichi Miyamoto; Sachiko Miyake; Miho Mizuno; Nobuyuki Oka; Susumu Kusunoki; Takashi Yamamura
Journal:  Brain       Date:  2006-07-10       Impact factor: 13.501

Review 2.  Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models.

Authors:  Francesca Bosetti
Journal:  J Neurochem       Date:  2007-04-02       Impact factor: 5.372

3.  Eicosenoids Modify Experimental Allergic Encephalomyelitis.

Authors:  Anthony T. Reder; Manjula Thapar; Anna Maria Sapugay; Mark A. Jensen
Journal:  Am J Ther       Date:  1995-09       Impact factor: 2.688

4.  Prostaglandin release in multiple sclerosis: correlation with disease activity.

Authors:  P Dore-Duffy; J O Donaldson; T Koff; M Longo; W Perry
Journal:  Neurology       Date:  1986-12       Impact factor: 9.910

5.  Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses.

Authors:  Suzana Marusic; Paresh Thakker; Jeffrey W Pelker; Nancy L Stedman; Katherine L Lee; John C McKew; Lixin Han; Xin Xu; Stan F Wolf; Adam J Borey; Junqing Cui; Marina W H Shen; Fran Donahue; Mina Hassan-Zahraee; Michael W Leach; Takao Shimizu; James D Clark
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

6.  Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease.

Authors:  Athena Kalyvas; Samuel David
Journal:  Neuron       Date:  2004-02-05       Impact factor: 17.173

Review 7.  The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases.

Authors:  Grace Y Sun; Lloyd A Horrocks; Akhlaq A Farooqui
Journal:  J Neurochem       Date:  2007-06-11       Impact factor: 5.372

8.  Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation.

Authors:  Florence Pinto; Talma Brenner; Phyllis Dan; Miron Krimsky; Saul Yedgar
Journal:  Glia       Date:  2003-12       Impact factor: 7.452

9.  COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-gamma and IL-10 production by inhibiting T-bet expression.

Authors:  Jia Ni; Ying-Yi Shu; Yi-Na Zhu; Yun-Feng Fu; Wei Tang; Xiang-Gen Zhong; Hui Wang; Yi-Fu Yang; Jin Ren; Ming-Wei Wang; Jian-Ping Zuo
Journal:  J Neuroimmunol       Date:  2007-04-17       Impact factor: 3.478

10.  Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis.

Authors:  Suzana Marusic; Michael W Leach; Jeffrey W Pelker; Mihai L Azoitei; Naonori Uozumi; Junqing Cui; Marina W H Shen; Charlene M DeClercq; Joy S Miyashiro; Brenda A Carito; Paresh Thakker; David L Simmons; John P Leonard; Takao Shimizu; James D Clark
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307

View more
  17 in total

1.  Anti-inflammatory effect of acetylpuerarin on eicosanoid signaling pathway in primary rat astrocytes.

Authors:  Yanxiao Xiang; Xinbing Wei; Lin Chen; Huiqing Liu; Xiaoqian Liu; Tian Wang; Xiumei Zhang
Journal:  J Mol Neurosci       Date:  2013-09-13       Impact factor: 3.444

2.  The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain.

Authors:  Jongho Lee; Karin Shmueli; Byeong-Teck Kang; Bing Yao; Masaki Fukunaga; Peter van Gelderen; Sara Palumbo; Francesca Bosetti; Afonso C Silva; Jeff H Duyn
Journal:  Neuroimage       Date:  2011-10-29       Impact factor: 6.556

3.  Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy.

Authors:  Tzipora C Falik Zaccai; David Savitzki; Yifat Zivony-Elboum; Thierry Vilboux; Eric C Fitts; Yishay Shoval; Limor Kalfon; Nadra Samra; Zohar Keren; Bella Gross; Natalia Chasnyk; Rachel Straussberg; James C Mullikin; Jamie K Teer; Dan Geiger; Daniel Kornitzer; Ora Bitterman-Deutsch; Abraham O Samson; Maki Wakamiya; Johnny W Peterson; Michelle L Kirtley; Iryna V Pinchuk; Wallace B Baze; William A Gahl; Robert Kleta; Yair Anikster; Ashok K Chopra
Journal:  Brain       Date:  2016-12-21       Impact factor: 13.501

4.  Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect.

Authors:  Neveen A Salem; Naglaa Assaf; Manal F Ismail; Yasser A Khadrawy; Mohga Samy
Journal:  Cell Mol Neurobiol       Date:  2015-10-14       Impact factor: 5.046

5.  Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.

Authors:  Andrea Manterola; Ana Bernal-Chico; Raffaela Cipriani; Manuel Canedo-Antelo; Álvaro Moreno-García; Mar Martín-Fontecha; Fernando Pérez-Cerdá; María Victoria Sánchez-Gómez; Silvia Ortega-Gutiérrez; J Mark Brown; Ku-Lung Hsu; Benjamin Cravatt; Carlos Matute; Susana Mato
Journal:  Biochem Pharmacol       Date:  2018-08-01       Impact factor: 5.858

6.  Differential expression of transcription factors and inflammation-, ROS-, and cell death-related genes in organotypic cultures in the modiolus, the organ of Corti and the stria vascularis of newborn rats.

Authors:  Johann Gross; Heidi Olze; Birgit Mazurek
Journal:  Cell Mol Neurobiol       Date:  2014-03-05       Impact factor: 5.046

7.  Tissue-specific differences in brain phosphodiesters in late-life major depression.

Authors:  David G Harper; J Eric Jensen; Caitlin Ravichandran; Yusuf Sivrioglu; Marisa Silveri; Dan V Iosifescu; Perry F Renshaw; Brent P Forester
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-11       Impact factor: 4.105

8.  Neuroprotective Effects of Melatonin during Demyelination and Remyelination Stages in a Mouse Model of Multiple Sclerosis.

Authors:  Hanin Abdulbaset Abo Taleb; Badrah Saeed Alghamdi
Journal:  J Mol Neurosci       Date:  2019-11-11       Impact factor: 3.444

9.  The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients.

Authors:  Agnieszka Morel; Elzbieta Miller; Michal Bijak; Joanna Saluk
Journal:  Mol Cell Biochem       Date:  2016-08-09       Impact factor: 3.396

10.  Misoprostol Reverse Hippocampal Neuron Cyclooxygenase-2 Downstream Signaling Imbalance in Aluminum-Overload Rats.

Authors:  Yuanxin Guo; Wenjuan Lei; Jianfeng Wang; Xinyue Hu; Yuling Wei; Chaonan Ji; Junqing Yang
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.